Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells

Journal of Neurochemistry

Volumn 104, Issue 1, 2008, Pages 89-99

  Delaune, A ^a,b   Corbiere C ^a   Benjelloun, F D ^a   Legrand, E ^a   Vannier, J P ^a   Ripoll, C ^b   Vasse, M ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b Faculté des Sciences et Techniques   (France)

Author keywords

Extracellular signal regulated kinases; Neuroblastoma; Neuronal differentiation; Promyelocytic leukemia nuclear bodies; Protein kinase C; Retinoic acid

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; RETINOIC ACID;

ARTICLE; CANCER CELL; CANCER PATIENT; CANCER THERAPY; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS INCLUSION BODY; DISEASE COURSE; HUMAN; IN VITRO STUDY; NERVE FIBER GROWTH; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; SUMOYLATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS STRUCTURES; CELL PROLIFERATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATOLYTIC AGENTS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEUROBLASTOMA; NUCLEAR PROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR SUPPRESSOR PROTEINS;

EID: 37249034722     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05019.x     Document Type: Article

References (32)

1. Ascoli C. A. Maul G. G. (1991) Identification of a novel nuclear domain. J. Cell Biol. 112, 785 795.
2. Benedetti L., Grignani F., Scicchitano B. M. et al. (1996) Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARα-mediated increase of type II transglutaminase. Blood 87, 1939 1950.
3. Borrow J., Goddard A. D., Sheer D. Solomon E. (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249, 1577 1580.
4. Cohen P. S., Seeger R. C., Triche T. J. Israel M. A. (1988) Detection of N-myc gene expression in neuroblastoma tumors by in situ hybridization. Am. J. Pathol. 131, 391 397.
5. Eksioglu-Demiralp E., Kitada S., Carson D., Garland J., Andreef M. Reed J. C. (2003) A method for functional evaluation of caspase activation pathways in intact lymphoid cells using electroporation-mediated protein delivery and flow cytometric analysis. J. Immunol. Methods 275, 41 56.
6. Encinas M., Iglesias M., Llecha N. Comella J. X. (1999) Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of neuroblastoma cell line SH-SY5Y. J. Neurochem. 73, 1409 1421.
7. Haussler M., Sidell N., Kelly M., Donaldson C., Altman A. Mangelsdorf D. (1983) Specific high-affinity binding and biologic action of retinoic acid in human neuroblastoma cell lines. Proc. Natl Acad. Sci. USA 80, 5525 5529.
8. Hayakawa F. Privalsky M. L. (2004) Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis. Cancer cell 5, 389 401.
9. Huang M. E., Ye Y. C., Chen S. R., Chai J. R., Lu J. X., Zhoa L., Gu L. J. Wang Z. Y. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567 572.
10. Hynds D. L., Spencer M. L., Andres D. A. Snow D. M. (2003) Rit promotes MEK-independent neurite branching in human neuroblastoma cells. J. Cell Sci. 116, 1925 1935.
11. Ishov A. M., Sotnokov A. G., Negorev D., Vladimirova O. V., Neff N., Kamitani T., Yeh E. T. H., Strauss J. F. Maul G. G. (1999) PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147, 221 233.
12. Jensen K., Shiels C. Freemont P. S. (2001) PML protein isoforms and the RBCC/TRIM motif. Oncogene 20, 7223 7233.
13. Joshi S., Guleria R. S., Pan J., DiPette D. Singh U. S. (2007) Heterogeneity in retinoic acid signalling in neuroblastomes: role of matrix metalloproteinases in retinoic acid-induced differentiation. Biochim. Biophys. Acta 1772, 1093 1102.
14. Kakizuka A., Miller W. H. Jr., Umesono K., Warrell R. P. Jr., Frankel S. R., Murty V. V., Dmitrovsky E. Evans R. M. (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663 674.
15. Kamitani T., Kito K., Nguyen H. P., Wada H., Fukuda-Kamitani T. Yeh E. T. H. (1998) Identification of three major sentrinization sites in PML. J. Biol. Chem. 273, 26675 26682.
16. Kim B., Leventhal P. S., Saltiel A. R. Feldman E. L. (1997) Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation. J. Biol. Chem. 34, 21268 21273.
17. Miloso M., Villa D., Crimi M., Galbiati S., Donzelli E., Nicolini G. Tredici G. (2004) Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is Erk independent and PKC dependent. J. Neurosc. Res. 75, 241 252.
18. Olsson A. K. Nanberg E. (2001) A functional role for ERK in gene induction, but not in neurite outgrowth in differentiating neuroblastoma cells. Exp. Cell Res. 265, 21 30.
19. Pahlman S., Ruusala A. I., Abrahamsson L., Mattsson M. E. Esscher T. (1984) Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ. 14, 135 144.
20. Parodi M. T., Varesio L. Tonini G. P. (1990) The specific inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), induces morphological change and cell differentiation of human neural crest-derived cell lineages. FEBS Lett. 269, 4 6.
21. Pettersson F., Couture M. C., Hanna N. Miller W. H. (2004) Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERK. Oncogene 23, 7053 7066.
22. Radominska-Pandya A., Chen G., Czernik P. J., Little J. M., Samokyszyn V. M., Carter C. A. Nowak G. (2000) Direct interaction of all-trans retinoic acid with protein kinase C (PKC). Implications for PKC signaling and cancer therapy. J. Biol. Chem. 275, 22324 22330.
23. Reynolds C. P., Matthay K. K., Villablanca J. G. Maurer B. J. (2003) Retinoid therapy of high-risk neuroblastoma. Cancer Lett. 197, 185 192.
24. Ruthardt M., Testa U., Nervi C., Ferrucci P. F., Grignani F., Puccetti E., Grognani F., Peschle C. Pelicci P. G. (1997) Opposite effects of the acute promyelocytic leukaemia PML-retinoic acid receptor α (RARα) and PLZF-RARα fusion proteins on retinoic acid signalling. Mol. Cell Biol. 17, 4859 4869.
25. Seidenfaden R., Krauter A. Hildebrandt H. (2006) The neural cell adhesion molecule NCAM regulates neuritogenesis by multiple mechanisms of interaction. Neurochem. Int. 49, 1 11.
26. Singh U. S., Pan J., Kao Y.-L., Joshi S., Young K. L. Baker K. M. (2003) Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J. Biol. Chem. 278, 391 399.
27. de The H., Lavau C., Marchio A., Chomienne C., Degos L. Dejean A. (1991) The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675 684.
28. White J. C., Highland M., Kaiser M. Clagett-Dame M. (2000) Vitamin A deficiency results in the dose-dependent acquisition of anterior character and shortening of the caudal hindbrain of the rat embryo. Dev. Biol. 220, 263 284.
29. Woo C. W., Lucarelli E. Thiele C. J. (2004) NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number. Oncogene 23, 1522 1530.
30. Yu E., Choi E. K. Kim C. J. (2003) Expression of promyelocytic leukaemia protein increases during the differentiation of human neuroblastoma cells. Virchows Arch. 442, 278 283.
31. Yu J. H., Nakajima A., Nakajima H., Diller L. R., Bloch K. D. Bloch D. B. (2004) Restoration of promyelocytic leukaemia protein-nuclear bodies in neuroblastoma cells enhances retinoic acid responsiveness. Cancer Res. 64, 928 933.
32. Zhong S., Muller S., Ronchetti S., Freemont P. S., Dejean A. Pandolfi P. P. (2000) Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748 2753.